FDA全球物质注册数据库（FDA Global Substance Registration System）
物质名称PAGIBAXIMAB
异名/同义词A110
A-110
BSYX-A110
IMMUNOGLOBULIN G1, ANTI (STAPHYLOCOCCUS EPIDERMIDIS LIPOTEICHOIC ACID) (HUMAN MOUSE MONOCLONAL HU96 110 HEAVY CHAIN), DISULFIDE WITH HUMAN MOUSE MONOCLONAL HU96 110 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1, ANTI (STAPHYLOCOCCUS EPIDERMIDIS LIPOTEICHOIC ACID) (HUMAN MOUSE MONOCLONAL HU96 110 HEAVY CHAIN), DISULPHIDE WITH HUMAN MOUSE MONOCLONAL HU96 110 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1, ANTI-(STAPHYLOCOCCUS EPIDERMIDIS LIPOTEICHOIC ACID)(HUMAN-MOUSE MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1, ANTI-(STAPHYLOCOCCUS EPIDERMIDIS LIPOTEICHOIC ACID)(HUMAN-MOUSE MONOCLONAL HEAVY CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL .KAPPA.-CHAIN, DIMER
PAGIBAXIMAB
PAGIBAXIMAB [INN]
PAGIBAXIMAB [USAN]
CAS登记号595566-61-3
物质唯一标识(Unique Ingredient Identifier)23KB56UHN9
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / protein
关联数据
  • 药品国际非专利名称数据库
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System